Alton L. Boynton
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Alton L. Boynton
Alton L. Boynton was last confirmed as Board Member at Northwest Biotherapeutics Inc (NWBO) in a filing dated April 16, 2021. The proxy statement of Northwest Biotherapeutics Inc reports total compensation of $375,000 for Alton L. Boynton in fiscal 2023, including a base salary of $375,000. Disclosed compensation is on record for 5 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2021-04-16
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Northwest Biotherapeutics Inc (NWBO) | Ph.D. Chief Scientific Officer and Secretary | $375,000 | $375,000 |
| 2022 | Northwest Biotherapeutics Inc (NWBO) | Ph.D. Chief Scientific Officer and Secretary | $350,000 | $450,000 |
| 2021 | Northwest Biotherapeutics Inc (NWBO) | Ph.D. Chief Scientific Officer and Secretary | $350,000 | $425,000 |
| 2019 | Northwest Biotherapeutics Inc (NWBO) | Chief Scientific Officer and Secretary | $325,000 | $345,000 |
| 2018 | Northwest Biotherapeutics Inc (NWBO) | Chief Scientific Officer and Secretary | $325,000 | $1,853,000 |
Recent activity
No call appearances or filed executive changes recorded yet.